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ABSTRACT
Stroke is the 2nd leading cause of death and 3rd leading cause of disability after cancer and ischemic heart disease. 
The recognition of acute stroke symptoms and knowledge about timely and prompt referral of a patient for possible 
thrombolysis is a need of time for which general practitioners (as they have to be the first responders many a times 
across Pakistan) need to be equipped with the advance knowledge about stroke treatment.
Methods: 
In this cross-sectional observational study we assessed a total of 100 GPs practicing within a radius of 60km from a 
tertiary care teaching hospital in Islamabad where thrombolysis is being offered routinely to patients with acute ischem-
ic stroke (AIS). They were interviewed using a standard questionnaire designed containing basic questions on stroke 
management.
Results: 
Of the 100 GPs interviewed, 70% felt that tissue plasminogen activator (tPA) can be used in treating AIS but only 20% 
chose tPA as the best treatment option while 31% opted for other agents like citicholine along with antiplatelets plus 
tPA.Only 28% were aware that tPA should be given within 3 hours while 64% mentioned intra-arterial thrombolysis as 
a treatment option.Only 54% felt the need for good diabetic control and 25% wanted aggressive lowering of blood 
pressure. 43% chose normal saline as fluid of choice.
 
Conclusions: 
Majority of the GPs are not aware about the beneficial effects of thrombolysis and are not updated regarding blood 
pressure and glucose control in the setting of acute ischemic stroke.
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O r i g i n a l  a r t i c l e
Introduction:
Stroke is the 2nd leading cause of death and 3rd 
leading cause of disability after cancer and ischemic 
heart disease [1]. Stroke is defined as the sudden 
non-convulsive, focal neurologic deficit of vascular 
origin. It encompasses mainly two types: ischemic 
stroke and hemorrhagic stroke. The intensity and 
duration of symptoms render many stroke sufferers 
unable to function or to perform work activities. Stroke 
has long been recognized as a major cause of work 
absenteeism and impaired productivity. The national 
annual indirect burden of illness due to stroke in the 
United States is estimated to be $75.2 billion [2]. 
Despite causing significant disability many challenges 
remain as clinicians and investigators continue to 
design interventions to improve stroke mortality and 
disability for all.
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The recognition of acute stroke symptoms and knowl-
edge about timely and prompt referral of a patient for 
possible thrombolysis is a need of time for which 
general practitioners (as they have to be the first 
responders many a times across Pakistan) need to be 
equipped with the advance knowledge about acute 
ischemic stroke treatment. Intravenous tissue plasmino-
gen activator (tPA) is the treatment of choice in the 
setting of acute stroke [3]. The limitations to intrave-
nous thrombolysis in stroke patients in our settings 
include: (1) delayed arrival to hospitals due to lack of 
awareness about the signs and symptoms of stroke and 
also available therapeutic options among the popula-
tion [4]; (2) lack of enough hospitals offering thromboly-
sis; (3) economic affordability; and (4) lack of aware-
ness of thrombolytic therapy in stroke both among the 
patients and referring physicians, pre-hospital delays 
and  lack of awareness about stroke thrombolysis 
among the medical professionals [5]. We studied the 
awareness about the treatment of stroke among 
general practitioners (GPs).
Materials and Methods:
This cross-sectional observational study was conducted 
within a radius of 60 km from a tertiary care teaching 
hospital in Islamabad (Pakistan) where thrombolysis 
(both intravenous and intra-arterial) is being offered 
routinely to patients with stroke. A total of 100 GPs 
were contacted through various electronic media like 
emails, text messages, phone calls, social applications 
while some were met at their clinics. They were 
interviewed after taking an informed consent using a 
standard questionnaire designed containing basic 
questions on the management of stroke. They were 
asked to fill the questionnaire. The data of the filled 
questionnaire by the GPs was compiled and analyzed 
using Microsoft Office Excel 2013.
Results:
A total of 100 GPs completed the questionnaire and 
their responses were included as follows:
 
Q1:  Opinion about tPA in the management of acute 
stroke: Of the 100 GPs, 70% agreed that tPA can 
be used in the treatment of acute stroke; 21% 
were not aware of this drug; 9%) believed that tPA 
is a drug undergoing clinical trial and no one felt 
that tPA has no role in the treatment of acute 
stroke.
Q2: Effective therapies for a patient with acute stroke: 
only 20% felt tPA is an effective treatment option. 
8% thought antiplatelet agent alone is effective. 
2% believed that a neuroprotective agent like 
citicholine is effective and 31% considered tPA, 
antiplatelet and a neuroprotective agent together 
to be beneficial. 39% opted for a combination of 
tPA and antiplatelet to be a better treatment 
option.
Q3: Window period for tPA: Only 28% GPs were aware 
that tPA needs to be given within 3 hours of onset 
of stroke; 15% did not know when to give this 
drug; 10% felt it can be given up to 12 hours; 22% 
felt it can be given within the first 6 hours and 25% 
felt it should be given within 4.5 hours.
Q4: Regarding Intra-arterial thrombolytic therapy for 
acute stroke: 64% felt it was a useful treatment 
option; 25% were not aware of this procedure; 2% 
believed that it has no role, and 9% thought that it 
has only been tried in clinical trials.
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Q5: Blood pressure (BP) control in acute stroke: In a 
patient with acute stroke with high blood 
pressures: of the 100 GPs, 47% felt that the BP 
should be lowered - systolic < 185 mmHg and 
diastolic < 110 mmHg; 12% felt that the systolic 
< 200 mmHg and diastolic < 130 mmHg would 
suffice; 25% felt that the BP to be lowered to 
normal with systolic 120 mmHg and diastolic 80 
mmHg; 2% wanted the BP to be reduced below 
normal with systolic <120 mmHg and diastolic 
<80 mmHg; and 14% were not sure of what 
should be the ideal BP in the setting of acute 
stroke
Q6: Regarding Blood sugar control in stroke: For a 
patient with acute ischemic stroke and a blood 
glucose of 289 mg/dL: Of the 100 GPs, 9.1% felt 
that the high glucose need not be treated;  54.5% 
felt that insulin should be started to get the blood 
glucose below 200 mg/dl;  13.1% opted for oral 
hypoglycemic agents to be effective; and 23.2% 
responders were not sure of the management of 
blood sugars in stroke.
Q7: Recommended intravenous fluids in acute 
ischemic stroke: If intravenous fluids are required 
for a patient with acute stroke, of the 100 GPs, 
25% opted for dextrose, 43% opted for 0.9% 
normal saline to be effective, 8% thought 0.45% 
saline to be suitable, 6% believed that no intrave-
nous fluid is required for acute ischemic stroke 
patients and 18% were not sure about the answer.
Discussion:
According to WHO statistics, 5.5 million deaths 
occurred due to stroke in 2002, estimating 20% of 
these deaths occurred in South Asia [6]. The American 
Heart & Stroke Association national guidelines recom-
mend tPA to be given within 4.5 hours of symptom 
onset in a patient with acute ischemic stroke has 
morbidity benefit [7]. However, there is no published 
data on the use of thrombolysis in Africa. Although tPA 
has demonstrated efficacy in improving outcomes but 
its use is often complicated by complex inclusion and 
exclusion criteria, risk of haemorrhage, requirement for 
intense patient monitoring, substantial cost and the 
potential for protocol violations leading to devastating 
complications [8].
In our setting, quite often the first likely contact of 
stroke patients will be a local general practitioner. There-
fore, it is cardinal that the local general practitioners 
are well aware of the various treatment options 
available for the stroke patients and also about the 
nearest center providing such treatment options for the 
timely and prompt referral. In our survey only 20% of 
the GPs opted for tPA as the best treatment option for 
a patient with acute ischemic stroke. Only 28% were 
aware that tPA needs to be given within the first 3 hours 
of symptom onset. Thus in this region of the country 
only one out of four potentially treatable cases of acute 
ischemic stroke will be referred promptly for possible 
thrombolytic therapy. In a German study, two-thirds of 
the GPs would immediately admit stroke-suspected 
patients [9]. A study in England has shown that visiting 
a GP can significantly delay patient arrival at the hospi-
tal [10].
There was a very inadequate knowledge seen regarding 
blood pressure control and management of blood 
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25% wanted an aggressive lowering of the BP which 
can be potentially detrimental to the patient [11]. High 
blood glucose can have disastrous effects on all types 
of acute brain injury. In this study, 54% of practicing 
general physicians felt the need to aggressively manage 
hyperglycemia and still, 25% chose dextrose to be the 
intravenous fluid of choice in patients with acute 
ischemic stroke. It is also strikingly noticeable that 
majority of the GPs chose aggressively marketed neuro-
protective drugs like citicoline over tPA. 
There are limitations in our study. This survey had 
sampled general practitioners only from a small 
geographic area of the city and hence the results 
cannot be generalized. However, the results of our 
study lead to the belief that there is a crucial need to 
rationalize and update the knowledge regarding the 
treatment of acute ischemic stroke in the midst of GPs 
in the country. Following this study, we are planning to 
organize a 24-hour acute stroke hotline. Any local 
practitioner in this region when coming in contact with 
a patient of acute ischemic stroke can immediately call 
and clarify instructions regarding timely and prompt 
referral for thrombolysis or clear any ambiguities regard-
ing the conservative treatment of acute ischemic 
stroke.
Conclusion:
Still in the current era of information and technology, a 
majority of the GPs are still not aware of the beneficial 
effects of thrombolysis and are not updated regarding 
blood pressure and glucose control in the setting of 
stroke. The patients could reach the emergency depart-
ment within the window period to be suitable for throm-
bolytic therapy. There is lack of awareness and knowl-
edge about treatment options in acute ischemic stroke 
amongst the referring general practitioners so the 
future educational campaigns and programs that will be 
organized should focus on the importance of stroke 
knowledge among general practitioners.
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